Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Cardiology Reports
Published in: Current Cardiology Reports 3/2012

01-06-2012 | Echocardiography (RM Lang, Section Editor)

Redefining the Role of Cardiovascular Imaging in Patients with Pulmonary Arterial Hypertension

Authors: Benjamin H. Freed, Amit R. Patel, Roberto M. Lang

Published in: Current Cardiology Reports | Issue 3/2012

Login to get access

Abstract

While pulmonary arterial hypertension is a disease primarily affecting the pulmonary vasculature, the right ventricle plays an integral part in the disease process. Although widely used, two-dimensional echocardiography is limited in visualizing the right ventricle and, therefore, assessment of its structure and function has been largely subjective or invasive. Advanced imaging modalities such as real-time three-dimensional echocardiography and cardiovascular magnetic resonance overcome many challenges of two-dimensional echocardiography and have provided further insight into the pathophysiology of pulmonary arterial hypertension. Indices of right ventricular function obtained from these noninvasive techniques are being assessed for their prognostic capabilities as well as their ability to monitor response to pulmonary arterial hypertension–specific therapies. Future research is needed to compare the accuracy, reproducibility, and prognostic value of each of these parameters to definitively establish the role of cardiovascular imaging in the management of patients with pulmonary arterial hypertension.
Literature
1.
Badesch DB, Champion HC, Sanchez MAG, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54:S55–66.PubMedCrossRef
2.
Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54:S43–54.PubMedCrossRef
3.
Chin KM, Kim NH, Rubin LJ. The right ventricle in pulmonary hypertension. Coron Arery Dis. 2005;16:13–8.CrossRef
4.
Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med. 2004;351:1425–36.PubMedCrossRef
5.
D’Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115:343–9.PubMed
6.
McLaughlin VV, Badesch DB, Delcroix M, et al. End points and clinical trial design in pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54:S97–S107.PubMedCrossRef
7.
•• Benza RL, Miller DP, Gomberg-Maitland M, et al. Predicting survival in pulmonary arterial hypertension: Insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation. 2010;122:164–72. This registry includes 2712 patients with PAH and developed a risk score based on numerous clinical, functional, and hemodynamic independent predictors of 1-year mortality.PubMedCrossRef
8.
Hinderliter AL, Willis 4th PW, Long W, et al. Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertension. Am J Cardiol. 1999;84:481–84.PubMedCrossRef
9.
Peacock AJ. Endpoints in trials of new therapies for pulmonary arterial hypertension. Eur Respir Dis. 2007;2:41–4.
10.
Agarwal R, Gomberg-Maitland M. Current therapeutics and practical management strategies for pulmonary arterial hypertension. Am Heart J. 2011;162:201–13.PubMedCrossRef
11.
• Bradlow WM, Hughes ML, Keenan NG, et al. Measuring the heart in pulmonary arterial hypertension (PAH): implications for trial study size. J Magn Reson Imaging. 2010;31:117–24. This is one of the few papers showing how excellent the reproducibility of CMR is in RV assessment in patients with PAH.PubMedCrossRef
12.
Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation. 2008;117:1717–31.PubMedCrossRef
13.
•• Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23:685–713. This is the most comprehensive 2D echocardiographic assessment of the right ventricle. These guidelines help to standardize assessment of the right ventricle using the most up-to-date measures of RV size and function.PubMedCrossRef
14.
Forfia P, Fisher MR, Mathai SC, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med. 2006;174:1034–41.PubMedCrossRef
15.
Yeo TC, Dujardin KS, Tei C, et al. Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. Am J Cardiol. 1998;81:1157–61.PubMedCrossRef
16.
La Gerche A, Ruxandra J, Voigt JU. Right ventricular function by strain echocardiography. Curr Opin Cardiol. 2010;25:430–6.PubMedCrossRef
17.
• Sachdev A, Villarraga HR, Frantz RP. Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertension. Chest. 2011;139:1299–309. This is an important paper examining a newly developed parameter for global RV function with 2DE in patients with PAH.PubMedCrossRef
18.
Galie N, Hinderliter AL, Torbicki A, et al. Effects of the oral endothelin-receptor anatagonist bosentan on echocardiographic and Doppler measures in patients with pulmonary arterial hypertension. J Am Coll Cardiol. 2003;41:1380–6.PubMedCrossRef
19.
van der Zwaan HB, Geleijnse ML, McGhie JS, et al. Right ventricular quantification in clinical practice: two-dimensional vs. three-dimensional echocardiography compared with cardiac magnetic resonance imaging. Eur J Echocardiogr. 2011;12:656–64.PubMedCrossRef
20.
• Sugeng L, Mor-Avi W, Weinert L, et al. Multimodality comparison of quantitative volumetric analysis of the right ventricle. JACC Cardiovasc Imaging. 2010;3:10–8. This paper examines both in vitro and in vivo assessment of the right ventricle using multimodality imaging. RV analysis is performed with identical post-processing software.PubMedCrossRef
21.
Grapsa J, O’Regan DP, Pavlopoulos H, et al. Right ventricular remodeling in pulmonary arterial hypertension with three-dimensional echocardiography: comparison with cardiac magnetic resonance imaging. Eur J Echocardiogr. 2010;11:64–73.PubMedCrossRef
22.
Benza RL, Biederman R, Murali S, Gupta H. Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension. J Am Coll Cardiol. 2008;52:1683–92.PubMedCrossRef
23.
Fratz S, Schuhbaeck A, Buchner C, et al. Comparison of accuracy of axial slices versus short-axis slices for measuring ventricular volumes by cardiac magnetic resonance in patients with corrected tetralogy of fallot. Am J Cardiol. 2009;103:1764–9.PubMedCrossRef
24.
Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham Jr TP. Normal human left and right ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson. 1999;1:7–21.PubMedCrossRef
25.
• van Wolferen SA, van de Veerdonk MC, Mauritz GJ, et al. Clinically significant change in stroke volume in pulmonary hypertension. Chest. 2011;139:1003–9. This is one of the first papers that looks at what is actually a clinically meaningful change in RV parameters using CMR.PubMedCrossRef
26.
van Wolferen SA, Marcus JT, Boonstra A, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J. 2007;28:1250–7.PubMedCrossRef
27.
Hagger D, Condliffe R, Woodhouse N, et al. Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension. Rheumatology. 2009;48:1137–42.PubMedCrossRef
28.
Gan CT, Lankhaar JW, Westerhof N, et al. Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest. 2007;132:1906–12.PubMedCrossRef
29.
Blyth KG, Groenning BA, Martin TN, et al. Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J. 2005;26:1993–9.PubMedCrossRef
30.
McCann GP, Gan CT, Beek AM, et al. Extent of MRI delayed enhancement of myocardial mass is related to right ventricular dysfunction in pulmonary artery hypertension. Am J Roentgenol. 2007;188:349–55.CrossRef
31.
Sanz J, Dellegrottaglie S, Kariisa M, et al. Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension. Am J Cardiol. 2007;100:731–5.PubMedCrossRef
32.
Junqueira FP, Macedo R, Coutinho AC, et al. Myocardial delayed enhancement in patients with pulmonary hypertension and right ventricular failure: evaluation by cardiac MRI. Br J Radiol. 2009;82:821–6.PubMedCrossRef
33.
Shehata ML, Lossnitzer D, Skrok J, et al. Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling. AJR Am J Roentgenol. 2011;196:87–94.PubMedCrossRef
34.
Freed BH, Gomberg-Maitland M, Chandra S. Contrast-enhanced cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension. Presented at the Society of Cardiovascular Magnetic Resonance/EuroCMR International Conference. Nice, France; February 3–6, 2011.
35.
Zafrir N, Zingerman B, Solodky A, et al. Use of noninvasive tools in primary pulmonary hypertension to assess the correlation of right ventricular function with functional capacity and to predict outcome. Int J Cardiovasc Imaging. 2007;23:209–15.PubMedCrossRef
36.
Kawut S, Horn EM, Berekashvili KK, et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol. 2005;95:199–203.PubMedCrossRef
37.
•• van de Veerdonk MC, Kind T, Marcus JT, et al. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol. 2011;58:2511–9. This is one of the first published papers showing the powerful, independent prognostic capability of CMR-derived RVEF in patients with PAH.PubMedCrossRef
38.
Wilkins MR, Paul GA, Strange JW, et al. Sildenafil versus endothelin receptor antagonist for pulmonary hypertension (SERAPH) study. Am J Respir Crit Care Med. 2005;171:1292–7.PubMedCrossRef
39.
Sciancalepore MA, Maffessanti F, Patel AR, et al. Three-dimensional analysis of interventricular septal curvature from cardiac magnetic resonance images for the evaluation of patients with pulmonary hypertension. Int J Cardiovasc Imaging 2011 [Epub ahead of print].
40.
Champion HC, Michelakis ED, Hassoun PM. Comprehensive invasive and noninvasive approach to the right ventricle pulmonary circulation unit: state of the art and clinical and research implications. Circulation. 2009;120:992–1007.PubMedCrossRef
41.
Sanz J, Kariisa M, Dellegrottaglie S, et al. Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC: Cardiovasc Imaging. 2009;2:286–95.CrossRef
42.
Shehata M, Basha TA, Tantawy WH, et al. Real-time single-heartbeat fast strain-encoded imaging of right ventricular regional function: normal versus chronic pulmonary hypertension. Magn Reson Med. 2010;64:98–106.PubMedCrossRef
43.
Vogel-claussen J, Skrok J, Shehata ML, et al. Right and left ventricular myocardial perfusion reserves correlate with right ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension. Radiology. 2011;258:119–27.PubMedCrossRef
44.
Bokhari S, Raina A, Rosenweig EB, et al. PET imaging may provide a novel biomarker and understanding of right ventricular dysfunction in patients with idiopathic pulmonary arterial hypertension. Circ Cardiovasc Imaging. 2011;4:641–7.PubMedCrossRef
45.
Shah SJ, Thenappan T, Rich S, et al. Value of exercise treadmill testing in the risk stratification of patients with pulmonary hypertension. Circ Heart Fail. 2009;2:278–86.PubMedCrossRef
Metadata
Title
Redefining the Role of Cardiovascular Imaging in Patients with Pulmonary Arterial Hypertension
Authors
Benjamin H. Freed
Amit R. Patel
Roberto M. Lang
Publication date
01-06-2012
Publisher
Current Science Inc.
Published in
Current Cardiology Reports / Issue 3/2012
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-012-0253-2

Other articles of this Issue 3/2012

Current Cardiology Reports 3/2012 Go to the issue

Congestive Heart Failure (J Lindenfeld, Section Editor)

Is Heart Rate a Treatment Target in Heart Failure?

Congestive Heart Failure (J Lindenfeld, Section Editor)

Role of Self-Care in the Patient with Heart Failure

Congestive Heart Failure (J Lindenfeld, Section Editor)

Isolated Ultrafiltration in Heart Failure Patients

Echocardiography (RM Lang, Section Editor)

Left Atrial Volume: Clinical Value Revisited

Congestive Heart Failure (J Lindenfeld, Section Editor)

Is Myocardial Recovery Possible and How Do You Measure It?

Echocardiography (RM Lang, Section Editor)

Diastolic Stress Test for the Evaluation of Exertional Dyspnea

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits